Wells Fargo analyst Joseph O’Dea downgraded Emerson (EMR) to Equal Weight from Overweight with a price target of $140, down from $150, as part of a Q3 earnings preview. The firm sees the company’s near-term lacks catalysts with a “downsized” exit rate growth in fiscal 2025 and tough margin compares in the first half of 2026. Valuation expansion for Emerson “likely needs earnings revision help,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson Electric Co. Receives ‘Buy’ Rating Amid Strong EPS Performance and Positive Outlook Despite Regional Demand Challenges
- Promising Outlook for Emerson Electric: Buy Rating Affirmed Due to Anticipated Growth in T&M and Discrete Segments
- Emerson Electric: Undervalued Growth Potential with Strategic Investments and Market Positioning
- Emerson upgraded to Equal Weight from Underweight at Barclays
- Emerson Electric Reports Strong Q3 2025 Results